A Multi-Criteria Decision Framework to Guide Treatment Decision-Making in Patients with Lenalidomide-Refractory Multiple Myeloma Post-DRd - European Medical Journal

Continue

A Multi-Criteria Decision Framework to Guide Treatment Decision-Making in Patients with Lenalidomide-Refractory Multiple Myeloma Post-DRd

Hematology
Download PDF

This publication was supported by Stemline Therapeutics Switzerland GmbH.

It is based on a abstract presented at the European Hematology Association (EHA) Congress, held from the 12th–15th June 2025.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

We’ve noticed you’re accessing
from North/South America.